Literature DB >> 25990255

Potassium Bicarbonate Supplementation Lowers Bone Turnover and Calcium Excretion in Older Men and Women: A Randomized Dose-Finding Trial.

Bess Dawson-Hughes1, Susan S Harris1, Nancy J Palermo1, Cheryl H Gilhooly1, M Kyla Shea1, Roger A Fielding1, Lisa Ceglia1.   

Abstract

The acid load accompanying modern diets may have adverse effects on bone and muscle metabolism. Treatment with alkaline salts of potassium can neutralize the acid load, but the optimal amount of alkali is not established. Our objective was to determine the effectiveness of two doses of potassium bicarbonate (KHCO3 ) compared with placebo on biochemical markers of bone turnover, and calcium and nitrogen (N) excretion. In this double-blind, randomized, placebo-controlled study, 244 men and women age 50 years and older were randomized to placebo or 1 mmol/kg or 1.5 mmol/kg of KHCO3 daily for 3 months; 233 completed the study. The primary outcomes were changes in 24-hour urinary N-telopeptide (NTX) and N; changes in these measures were compared across the treatment groups. Exploratory outcomes included 24-hour urinary calcium excretion, serum amino-terminal propeptide of type I procollagen (P1NP), and muscle strength and function assessments. The median administered doses in the low-dose and high-dose groups were 81 mmol/day and 122 mmol/day, respectively. When compared with placebo, urinary NTX declined significantly in the low-dose group (p = 0.012, after adjustment for baseline NTX, gender, and change in urine creatinine) and serum P1NP declined significantly in the low-dose group (p = 0.004, adjusted for baseline P1NP and gender). Urinary calcium declined significantly in both KHCO3 groups versus placebo (p < 0.001, adjusted for baseline urinary calcium, gender, and changes in urine creatinine and calcium intake). There was no significant effect of either dose of KHCO3 on urinary N excretion or on the physical strength and function measures. KHCO3 has favorable effects on bone turnover and calcium excretion and the lower dose appears to be the more effective dose. Long-term trials to assess the effect of alkali on bone mass and fracture risk are needed.
© 2015 American Society for Bone and Mineral Research.

Entities:  

Keywords:  ACID-BASE; BICARBONATE; BONE; OSTEOPOROSIS; POTASSIUM

Mesh:

Substances:

Year:  2015        PMID: 25990255      PMCID: PMC4817273          DOI: 10.1002/jbmr.2554

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  27 in total

1.  Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health?

Authors:  S A New; S P Robins; M K Campbell; J C Martin; M J Garton; C Bolton-Smith; D A Grubb; S J Lee; D M Reid
Journal:  Am J Clin Nutr       Date:  2000-01       Impact factor: 7.045

2.  Muscle power of the ankle flexors predicts functional performance in community-dwelling older women.

Authors:  T Suzuki; J F Bean; R A Fielding
Journal:  J Am Geriatr Soc       Date:  2001-09       Impact factor: 5.562

3.  Neutralization of Western diet inhibits bone resorption independently of K intake and reduces cortisol secretion in humans.

Authors:  Marc Maurer; Walter Riesen; Juergen Muser; Henry N Hulter; Reto Krapf
Journal:  Am J Physiol Renal Physiol       Date:  2002-09-24

4.  Potassium citrate supplementation results in sustained improvement in calcium balance in older men and women.

Authors:  Kendall F Moseley; Connie M Weaver; Lawrence Appel; Anthony Sebastian; Deborah E Sellmeyer
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

5.  Potassium citrate prevents increased urine calcium excretion and bone resorption induced by a high sodium chloride diet.

Authors:  Deborah E Sellmeyer; Monique Schloetter; Anthony Sebastian
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

6.  The relationship between leg power and physical performance in mobility-limited older people.

Authors:  Jonathan F Bean; Dan K Kiely; Seth Herman; Suzanne G Leveille; Kelly Mizer; Walter R Frontera; Roger A Fielding
Journal:  J Am Geriatr Soc       Date:  2002-03       Impact factor: 5.562

7.  The DASH diet and sodium reduction improve markers of bone turnover and calcium metabolism in adults.

Authors:  Pao-Hwa Lin; Fiona Ginty; Lawrence J Appel; Mikel Aickin; Arline Bohannon; Patrick Garnero; Denis Barclay; Laura P Svetkey
Journal:  J Nutr       Date:  2003-10       Impact factor: 4.798

8.  Effects of potassium citrate supplementation on bone metabolism.

Authors:  M Marangella; M Di Stefano; S Casalis; S Berutti; P D'Amelio; G C Isaia
Journal:  Calcif Tissue Int       Date:  2004-04       Impact factor: 4.333

9.  Bone mineral density and dietary patterns in older adults: the Framingham Osteoporosis Study.

Authors:  Katherine L Tucker; Honglei Chen; Marian T Hannan; L Adrienne Cupples; Peter W F Wilson; David Felson; Douglas P Kiel
Journal:  Am J Clin Nutr       Date:  2002-07       Impact factor: 7.045

10.  Precision of single vs bilateral hip bone mineral density scans.

Authors:  Jennifer White; Susan S Harris; Gerard E Dallal; Bess Dawson-Hughes
Journal:  J Clin Densitom       Date:  2003       Impact factor: 2.963

View more
  20 in total

1.  Abnormal distal renal tubular acidification in patients with low bone mass: prevalence and impact of alkali treatment.

Authors:  Jerzy Jan Sromicki; Bernhard Hess
Journal:  Urolithiasis       Date:  2016-07-13       Impact factor: 3.436

2.  Dietary potassium intake is beneficial to bone health in a low calcium intake population: the Korean National Health and Nutrition Examination Survey (KNHANES) (2008-2011).

Authors:  S H Kong; J H Kim; A R Hong; J H Lee; S W Kim; C S Shin
Journal:  Osteoporos Int       Date:  2017-01-16       Impact factor: 4.507

3.  Increasing alkali supplementation decreases urinary nitrogen excretion when adjusted for same day nitrogen intake.

Authors:  L Ceglia; B Dawson-Hughes
Journal:  Osteoporos Int       Date:  2017-08-25       Impact factor: 4.507

4.  Association of Urinary Citrate With Acid-Base Status, Bone Resorption, and Calcium Excretion in Older Men and Women.

Authors:  M Kyla Shea; Bess Dawson-Hughes
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

Review 5.  Benefits and safety of dietary protein for bone health-an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation.

Authors:  R Rizzoli; E Biver; J-P Bonjour; V Coxam; D Goltzman; J A Kanis; J Lappe; L Rejnmark; S Sahni; C Weaver; H Weiler; J-Y Reginster
Journal:  Osteoporos Int       Date:  2018-05-08       Impact factor: 4.507

6.  Response to Fenton and Fenton: evidence does not support the alkaline diet.

Authors:  B Dawson-Hughes; P J Mitchell; C Cooper; C M Gordon; R Rizzoli
Journal:  Osteoporos Int       Date:  2016-02-08       Impact factor: 4.507

Review 7.  Nutritional Supplements and Skeletal Health.

Authors:  Laila S Tabatabai; Deborah E Sellmeyer
Journal:  Curr Osteoporos Rep       Date:  2021-01-09       Impact factor: 5.096

8.  Heterozygosity for a Pathogenic Variant in SLC12A3 That Causes Autosomal Recessive Gitelman Syndrome Is Associated with Lower Serum Potassium.

Authors:  Xuesi Wan; James Perry; Haichen Zhang; Feng Jin; Kathleen A Ryan; Cristopher Van Hout; Jeffrey Reid; John Overton; Aris Baras; Zhe Han; Elizabeth Streeten; Yanbing Li; Braxton D Mitchell; Alan R Shuldiner; Mao Fu
Journal:  J Am Soc Nephrol       Date:  2021-02-04       Impact factor: 10.121

9.  Effect of Acid or Base Interventions on Bone Health: A Systematic Review, Meta-Analysis, and Meta-Regression.

Authors:  Yibing Han; Min An; Li Yang; Liuran Li; Shitao Rao; Yanzhen Cheng
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

Review 10.  Acid-base balance of the diet-implications for bone and muscle.

Authors:  Bess Dawson-Hughes
Journal:  Eur J Clin Nutr       Date:  2020-08       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.